Walleye Trading’s Clover Health Investments CLOV Stock Holding History

Walleye Trading’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65.1K	Sell	37,000 -177,200	-83%	-$384K	﹤0.01%	3609
2025 Q4	$503K	Buy	214,200 +199,100	+1,319%	+$544K	﹤0.01%	2818
2025 Q3	$46.2K	Sell	15,100 -13,200	-47%	-$37.7K	﹤0.01%	3983
2025 Q2	$79K	Sell	28,300 -4,000	-12%	-$13.2K	﹤0.01%	3682
2025 Q1	$116K	Buy	32,300 +19,000	+143%	+$76.3K	﹤0.01%	3329
2024 Q4	$41.9K	Buy	+13,300	New	+$47.5K	﹤0.01%	3829
2024 Q2	–	Sell	-10,000	Closed	-$7.94K	–	4359
2024 Q1	$7.94K	Buy	10,000 +5,300	+113%	+$4.82K	﹤0.01%	4351
2023 Q4	$4.47K	Buy	+4,700	New	+$4.62K	﹤0.01%	4729
2022 Q2	–	Sell	-7,600	Closed	-$27K	–	5178
2022 Q1	$27K	Buy	+7,600	New	+$22K	﹤0.01%	4691
2021 Q4	–	Sell	-26,900	Closed	-$199K	–	5406
2021 Q3	$199K	Buy	+26,900	New	+$230K	﹤0.01%	3846

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Trading's CLOV Position: Q1 2026 in Review

Walleye Trading reduced its Clover Health Investments (CLOV) stake by 0.09% in Q1 2026, selling an estimated $200 and leaving 99,483 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

Walleye Trading first reported a position in CLOV in Q2 2020 and has held it in 8 quarters since. The position peaked at $2.22M in Q2 2020. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

Walleye Trading held 99,483 shares of Clover Health Investments worth $175K as of Q1 2026.
Walleye Trading sold 92 Clover Health Investments shares in Q1 2026, an estimated $200.
Clover Health Investments made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3194 holding.
Walleye Trading first reported a position in Clover Health Investments in Q2 2020 and has held it in 8 quarters since.
Walleye Trading's Clover Health Investments position peaked at $2.22M in Q2 2020.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.